Cyclophosphamide as a first-line therapy in LGL leukemia - Vigipallia

0 avis

Cyclophosphamide as a first-line therapy in LGL leukemia

Archive ouverte

Moignet, A. | Hasanali, Z. | Zambello, R. | Pavan, L. | Bareau, B. | Tournilhac, O. | Roussel, Mikaël | Fest, T. | Awwad, A. | Baab, K. | Semenzato, G. | Houot, R. | Loughran, T. P. | Lamy, T.

Edité par CCSD ; Springer Nature -

International audience

Langue: en

Indexation

Consulter en ligne

Consulter le document

Consulter le document

Consulter le document

Suggestions

Du même auteur

Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients.

Archive ouverte | Poullot, Elsa | CCSD

International audience

Prospective, Multicentric Phase II Randomized Trial Comparing the Efficacy of Methotrexate or Cyclophosphamide in Large Granular Lymphocytic Leukemia: A French National Study. Report on the Interim Analysis

Archive ouverte | Lamy, T. | CCSD

International audience

Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients

Archive ouverte | Rossille, D. | CCSD

International audience

Chargement des enrichissements...